METTL5-mediated rRNA modification controls prostate cancer progression through the IRF7/DNA2 axis and mitophagy regulation

Ruifeng Yang, Qintao Ge, Fengyao Wu, Manmei Long, Bingyu Li, Zhe Hong, Wenhao Xu, Miaomiao Guo, Tao Feng, Xi Tian, Wei Zhang, Kun Chang, Fangning Wan, Zhi Shang, Zhongyuan Wang, Ming Zhan, Bin Xu, Dingwei Ye

Open source

DOI
10.1038/s41388-026-03867-w
Published
2026-07-13
Container
Oncogene
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41388-026-03867-w,
  title = {METTL5-mediated rRNA modification controls prostate cancer progression through the IRF7/DNA2 axis and mitophagy regulation},
  author = {Ruifeng Yang and Qintao Ge and Fengyao Wu and Manmei Long and Bingyu Li and Zhe Hong and Wenhao Xu and Miaomiao Guo and Tao Feng and Xi Tian and Wei Zhang and Kun Chang and Fangning Wan and Zhi Shang and Zhongyuan Wang and Ming Zhan and Bin Xu and Dingwei Ye},
  year = {2026},
  journal = {Oncogene},
  doi = {10.1038/s41388-026-03867-w},
  url = {https://doi.org/10.1038/s41388-026-03867-w}
}

RIS

TY  - JOUR
TI  - METTL5-mediated rRNA modification controls prostate cancer progression through the IRF7/DNA2 axis and mitophagy regulation
AU  - Ruifeng Yang
AU  - Qintao Ge
AU  - Fengyao Wu
AU  - Manmei Long
AU  - Bingyu Li
AU  - Zhe Hong
AU  - Wenhao Xu
AU  - Miaomiao Guo
AU  - Tao Feng
AU  - Xi Tian
AU  - Wei Zhang
AU  - Kun Chang
AU  - Fangning Wan
AU  - Zhi Shang
AU  - Zhongyuan Wang
AU  - Ming Zhan
AU  - Bin Xu
AU  - Dingwei Ye
PY  - 2026
JO  - Oncogene
DO  - 10.1038/s41388-026-03867-w
UR  - https://doi.org/10.1038/s41388-026-03867-w
ER  - 

APA

Yang, R., Ge, Q., Wu, F., Long, M., Li, B., Hong, Z., Xu, W., Guo, M., Feng, T., Tian, X., Zhang, W., Chang, K., Wan, F., Shang, Z., Wang, Z., Zhan, M., Xu, B., & Ye, D. (2026). METTL5-mediated rRNA modification controls prostate cancer progression through the IRF7/DNA2 axis and mitophagy regulation. Oncogene. https://doi.org/10.1038/s41388-026-03867-w

Source records